Laurent Gapin
Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Killer T-Cells | 24 | 2022 | 66 | 6.550 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 35 | 2024 | 335 | 4.530 |
Why?
| | Thymus Gland | 21 | 2024 | 317 | 3.460 |
Why?
| | T-Lymphocyte Subsets | 17 | 2024 | 422 | 3.010 |
Why?
| | Killer Cells, Natural | 26 | 2025 | 475 | 2.810 |
Why?
| | Antigens, CD1d | 25 | 2020 | 68 | 2.430 |
Why?
| | Antigens, CD1 | 16 | 2021 | 60 | 2.410 |
Why?
| | Cell Differentiation | 16 | 2026 | 2064 | 2.210 |
Why?
| | T-Lymphocytes | 22 | 2024 | 2045 | 2.110 |
Why?
| | Mucosal-Associated Invariant T Cells | 4 | 2025 | 37 | 1.960 |
Why?
| | Receptors, Antigen, T-Cell | 16 | 2024 | 728 | 1.910 |
Why?
| | Histocompatibility Antigens Class I | 7 | 2016 | 208 | 1.200 |
Why?
| | Immunity, Innate | 4 | 2024 | 856 | 1.200 |
Why?
| | Thymocytes | 5 | 2020 | 34 | 1.050 |
Why?
| | T-Cell Antigen Receptor Specificity | 6 | 2017 | 52 | 1.030 |
Why?
| | Intestinal Mucosa | 4 | 2025 | 675 | 1.020 |
Why?
| | Mice, Inbred C57BL | 38 | 2025 | 6068 | 1.000 |
Why?
| | Mice | 72 | 2026 | 18562 | 0.970 |
Why?
| | Animals | 86 | 2026 | 38352 | 0.930 |
Why?
| | Histocompatibility Antigens Class II | 11 | 2020 | 366 | 0.910 |
Why?
| | Histocompatibility Antigens | 4 | 2019 | 103 | 0.860 |
Why?
| | Antigen Presentation | 9 | 2018 | 216 | 0.860 |
Why?
| | Th17 Cells | 1 | 2025 | 104 | 0.830 |
Why?
| | CD8-Positive T-Lymphocytes | 13 | 2026 | 949 | 0.830 |
Why?
| | Autoantigens | 6 | 2020 | 432 | 0.820 |
Why?
| | Glycolipids | 5 | 2018 | 51 | 0.810 |
Why?
| | Colitis | 3 | 2025 | 280 | 0.790 |
Why?
| | Colon | 2 | 2025 | 305 | 0.780 |
Why?
| | Evolution, Molecular | 3 | 2019 | 514 | 0.760 |
Why?
| | CD4-Positive T-Lymphocytes | 10 | 2026 | 1147 | 0.730 |
Why?
| | Single-Cell Analysis | 3 | 2024 | 363 | 0.710 |
Why?
| | Mice, Knockout | 19 | 2025 | 3148 | 0.660 |
Why?
| | Galactosylceramides | 11 | 2012 | 27 | 0.650 |
Why?
| | Minor Histocompatibility Antigens | 3 | 2016 | 47 | 0.610 |
Why?
| | Immunologic Memory | 9 | 2025 | 376 | 0.590 |
Why?
| | Major Histocompatibility Complex | 6 | 2024 | 229 | 0.580 |
Why?
| | Lymphocyte Activation | 17 | 2020 | 1143 | 0.570 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 6 | 2012 | 21 | 0.560 |
Why?
| | Flow Cytometry | 7 | 2018 | 1193 | 0.550 |
Why?
| | Models, Immunological | 3 | 2007 | 101 | 0.530 |
Why?
| | Demethylation | 1 | 2017 | 4 | 0.510 |
Why?
| | Phenotype | 3 | 2024 | 3202 | 0.500 |
Why?
| | Genes, MHC Class I | 1 | 2016 | 36 | 0.490 |
Why?
| | Wasp Venoms | 1 | 2016 | 4 | 0.480 |
Why?
| | Bee Venoms | 1 | 2016 | 9 | 0.480 |
Why?
| | Mice, Inbred BALB C | 11 | 2019 | 1272 | 0.470 |
Why?
| | Immunity, Mucosal | 2 | 2014 | 99 | 0.460 |
Why?
| | Autoimmunity | 8 | 2020 | 928 | 0.450 |
Why?
| | T-Box Domain Proteins | 6 | 2007 | 105 | 0.440 |
Why?
| | Cells, Cultured | 11 | 2020 | 4178 | 0.440 |
Why?
| | Mice, Transgenic | 12 | 2024 | 2199 | 0.390 |
Why?
| | Pterins | 1 | 2012 | 7 | 0.380 |
Why?
| | Hypersensitivity | 1 | 2016 | 266 | 0.370 |
Why?
| | Peptide Fragments | 7 | 2019 | 707 | 0.370 |
Why?
| | Antigens | 8 | 2020 | 349 | 0.370 |
Why?
| | Protein Conformation | 7 | 2018 | 943 | 0.360 |
Why?
| | Globosides | 2 | 2011 | 2 | 0.350 |
Why?
| | Folic Acid | 1 | 2012 | 197 | 0.340 |
Why?
| | Self Tolerance | 1 | 2010 | 26 | 0.320 |
Why?
| | Dendritic Cells | 6 | 2013 | 506 | 0.300 |
Why?
| | Interferon-gamma | 8 | 2020 | 792 | 0.300 |
Why?
| | Transcription Factors | 6 | 2016 | 1742 | 0.300 |
Why?
| | CD8 Antigens | 3 | 2013 | 74 | 0.290 |
Why?
| | Th1 Cells | 2 | 2007 | 142 | 0.290 |
Why?
| | Signal Transduction | 5 | 2020 | 5282 | 0.290 |
Why?
| | Muramidase | 4 | 2002 | 67 | 0.280 |
Why?
| | Humans | 39 | 2025 | 145077 | 0.280 |
Why?
| | Immune Tolerance | 3 | 2020 | 384 | 0.270 |
Why?
| | Escherichia coli | 1 | 2013 | 855 | 0.270 |
Why?
| | Lymphocyte Subsets | 2 | 2005 | 87 | 0.270 |
Why?
| | Cell Line | 7 | 2020 | 2911 | 0.260 |
Why?
| | Lipids | 5 | 2021 | 701 | 0.260 |
Why?
| | Galactosyltransferases | 1 | 2007 | 12 | 0.260 |
Why?
| | Hybridomas | 6 | 2019 | 235 | 0.260 |
Why?
| | Protein Binding | 9 | 2019 | 2277 | 0.250 |
Why?
| | Early Growth Response Protein 2 | 2 | 2018 | 10 | 0.250 |
Why?
| | Genes, T-Cell Receptor alpha | 2 | 2003 | 12 | 0.240 |
Why?
| | B-Lymphocytes | 3 | 2025 | 890 | 0.240 |
Why?
| | Antigens, Bacterial | 3 | 2017 | 125 | 0.240 |
Why?
| | Cytokines | 5 | 2025 | 2101 | 0.230 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2025 | 25 | 0.230 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2025 | 36 | 0.230 |
Why?
| | Receptors, Lysophosphatidic Acid | 1 | 2025 | 40 | 0.230 |
Why?
| | Islets of Langerhans Transplantation | 1 | 2026 | 70 | 0.230 |
Why?
| | Cell Movement | 2 | 2007 | 978 | 0.220 |
Why?
| | Gene Expression Profiling | 3 | 2020 | 1829 | 0.220 |
Why?
| | Immunophenotyping | 5 | 2018 | 327 | 0.220 |
Why?
| | Immunoglobulin Variable Region | 4 | 2012 | 80 | 0.220 |
Why?
| | Crystallography, X-Ray | 3 | 2018 | 484 | 0.220 |
Why?
| | Interleukin-15 | 5 | 2013 | 100 | 0.210 |
Why?
| | Peptides | 5 | 2016 | 1002 | 0.210 |
Why?
| | Models, Molecular | 8 | 2013 | 1603 | 0.210 |
Why?
| | Anus Neoplasms | 1 | 2024 | 33 | 0.210 |
Why?
| | Gene Expression Regulation | 4 | 2013 | 2633 | 0.200 |
Why?
| | Immunotherapy | 2 | 2026 | 673 | 0.200 |
Why?
| | CD40 Antigens | 4 | 2014 | 90 | 0.200 |
Why?
| | Rectal Neoplasms | 1 | 2024 | 156 | 0.190 |
Why?
| | Amino Acid Sequence | 8 | 2019 | 2149 | 0.180 |
Why?
| | Surface Plasmon Resonance | 5 | 2013 | 91 | 0.180 |
Why?
| | Hematologic Neoplasms | 1 | 2024 | 162 | 0.170 |
Why?
| | Mutation | 5 | 2019 | 4132 | 0.170 |
Why?
| | Interleukin-4 | 4 | 2003 | 213 | 0.170 |
Why?
| | Strongylida Infections | 1 | 2021 | 8 | 0.170 |
Why?
| | Syk Kinase | 1 | 2020 | 22 | 0.160 |
Why?
| | Retroviridae | 2 | 2013 | 104 | 0.160 |
Why?
| | H-2 Antigens | 1 | 1999 | 112 | 0.150 |
Why?
| | Inflammation | 3 | 2025 | 2911 | 0.150 |
Why?
| | Amino Acid Motifs | 1 | 2019 | 225 | 0.150 |
Why?
| | Complementarity Determining Regions | 6 | 2012 | 53 | 0.150 |
Why?
| | Binding Sites | 3 | 2018 | 1314 | 0.150 |
Why?
| | Immunity, Cellular | 1 | 2020 | 273 | 0.140 |
Why?
| | Respiratory Hypersensitivity | 2 | 2010 | 69 | 0.140 |
Why?
| | Immune System | 2 | 2013 | 182 | 0.140 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 141 | 0.140 |
Why?
| | Immunodominant Epitopes | 1 | 1998 | 28 | 0.140 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 452 | 0.140 |
Why?
| | Insulin | 3 | 2026 | 2512 | 0.140 |
Why?
| | NFATC Transcription Factors | 1 | 2018 | 93 | 0.140 |
Why?
| | Mycolic Acids | 1 | 2017 | 7 | 0.130 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2020 | 249 | 0.130 |
Why?
| | Selection, Genetic | 1 | 2019 | 258 | 0.130 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4605 | 0.130 |
Why?
| | Cell Wall | 1 | 2017 | 62 | 0.130 |
Why?
| | Mutagenesis | 3 | 2013 | 193 | 0.130 |
Why?
| | Melanoma | 1 | 2024 | 813 | 0.130 |
Why?
| | Histone Demethylases | 1 | 2017 | 38 | 0.130 |
Why?
| | Viral Vaccines | 1 | 1998 | 108 | 0.120 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2026 | 3865 | 0.120 |
Why?
| | Mice, Inbred NOD | 4 | 2026 | 619 | 0.120 |
Why?
| | Transcription Activator-Like Effector Nucleases | 1 | 2016 | 6 | 0.120 |
Why?
| | Skin Neoplasms | 1 | 2024 | 863 | 0.120 |
Why?
| | Cell Lineage | 2 | 2013 | 379 | 0.120 |
Why?
| | Protein Isoforms | 1 | 2018 | 405 | 0.120 |
Why?
| | Ovalbumin | 3 | 2014 | 195 | 0.120 |
Why?
| | Staphylococcal Infections | 1 | 2020 | 390 | 0.120 |
Why?
| | Skin | 1 | 2021 | 766 | 0.120 |
Why?
| | Lymph Nodes | 2 | 2021 | 505 | 0.120 |
Why?
| | Alleles | 2 | 2017 | 884 | 0.120 |
Why?
| | Latent Tuberculosis | 1 | 2016 | 71 | 0.120 |
Why?
| | Tissue Distribution | 1 | 2016 | 329 | 0.110 |
Why?
| | Coculture Techniques | 2 | 2013 | 251 | 0.110 |
Why?
| | Receptors, Natural Killer Cell | 2 | 2011 | 16 | 0.110 |
Why?
| | Adoptive Transfer | 4 | 2020 | 220 | 0.110 |
Why?
| | Bacterial Vaccines | 1 | 2014 | 63 | 0.100 |
Why?
| | Amino Acids | 2 | 2009 | 520 | 0.100 |
Why?
| | Germ Cells | 2 | 2016 | 66 | 0.100 |
Why?
| | Mycobacterium tuberculosis | 1 | 2017 | 335 | 0.100 |
Why?
| | Epitopes | 3 | 2011 | 491 | 0.100 |
Why?
| | Adaptive Immunity | 1 | 2014 | 171 | 0.100 |
Why?
| | DNA-Binding Proteins | 1 | 2020 | 1495 | 0.100 |
Why?
| | Endopeptidase K | 1 | 2013 | 18 | 0.100 |
Why?
| | Interleukins | 1 | 2014 | 253 | 0.090 |
Why?
| | Sulfoglycosphingolipids | 1 | 2012 | 3 | 0.090 |
Why?
| | Polymerase Chain Reaction | 3 | 2012 | 1058 | 0.090 |
Why?
| | Cell Survival | 2 | 2025 | 1113 | 0.090 |
Why?
| | Interleukin-10 | 2 | 2026 | 311 | 0.090 |
Why?
| | Proteolysis | 1 | 2013 | 177 | 0.090 |
Why?
| | CD40 Ligand | 1 | 2012 | 40 | 0.090 |
Why?
| | Burkitt Lymphoma | 1 | 2012 | 63 | 0.090 |
Why?
| | Trihexosylceramides | 1 | 2011 | 4 | 0.090 |
Why?
| | Interleukin-2 Receptor beta Subunit | 2 | 2013 | 26 | 0.090 |
Why?
| | Cell Proliferation | 5 | 2020 | 2545 | 0.090 |
Why?
| | Histones | 1 | 2017 | 658 | 0.090 |
Why?
| | Promoter Regions, Genetic | 2 | 2013 | 1259 | 0.080 |
Why?
| | Th2 Cells | 2 | 2003 | 183 | 0.080 |
Why?
| | Immunoglobulin Joining Region | 2 | 2001 | 10 | 0.080 |
Why?
| | Molecular Sequence Data | 6 | 2011 | 2914 | 0.080 |
Why?
| | CD27 Ligand | 1 | 2009 | 9 | 0.080 |
Why?
| | Multiprotein Complexes | 1 | 2011 | 173 | 0.080 |
Why?
| | Epitopes, T-Lymphocyte | 3 | 2019 | 186 | 0.070 |
Why?
| | Lipid Metabolism | 1 | 2013 | 527 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1057 | 0.070 |
Why?
| | Immunization | 3 | 2013 | 375 | 0.070 |
Why?
| | Neoplasms | 1 | 2024 | 2932 | 0.070 |
Why?
| | Biomarkers | 2 | 2018 | 4283 | 0.070 |
Why?
| | Crystallography | 1 | 2007 | 27 | 0.070 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2007 | 14 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.070 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2007 | 18 | 0.070 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2008 | 227 | 0.070 |
Why?
| | Female | 12 | 2026 | 78355 | 0.070 |
Why?
| | Receptors, Retinoic Acid | 1 | 2007 | 43 | 0.070 |
Why?
| | Receptors, CXCR3 | 1 | 2007 | 16 | 0.060 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2007 | 100 | 0.060 |
Why?
| | Receptors, Chemokine | 1 | 2007 | 48 | 0.060 |
Why?
| | Adjuvants, Immunologic | 2 | 2014 | 246 | 0.060 |
Why?
| | Estrogen Antagonists | 1 | 2007 | 49 | 0.060 |
Why?
| | Allergens | 1 | 2010 | 394 | 0.060 |
Why?
| | Clone Cells | 3 | 2017 | 269 | 0.060 |
Why?
| | RNA, Messenger | 3 | 2003 | 2862 | 0.060 |
Why?
| | Tamoxifen | 1 | 2007 | 218 | 0.060 |
Why?
| | Vaccination | 1 | 2014 | 1424 | 0.060 |
Why?
| | Time Factors | 2 | 2013 | 7120 | 0.060 |
Why?
| | Interleukin-7 | 2 | 2002 | 65 | 0.060 |
Why?
| | Cross Reactions | 2 | 2017 | 135 | 0.060 |
Why?
| | Forkhead Box Protein O1 | 1 | 2025 | 35 | 0.060 |
Why?
| | Interleukin-12 | 2 | 2020 | 121 | 0.060 |
Why?
| | Genes, T-Cell Receptor beta | 2 | 2001 | 23 | 0.050 |
Why?
| | T-Lymphocytes, Cytotoxic | 2 | 2012 | 179 | 0.050 |
Why?
| | Receptors, Estrogen | 1 | 2007 | 470 | 0.050 |
Why?
| | Transcription, Genetic | 3 | 2020 | 1507 | 0.050 |
Why?
| | Graft Survival | 1 | 2026 | 528 | 0.050 |
Why?
| | Heterozygote | 1 | 2024 | 316 | 0.050 |
Why?
| | Lymphopenia | 2 | 2002 | 69 | 0.050 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 1 | 2002 | 37 | 0.050 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 2001 | 27 | 0.050 |
Why?
| | Structure-Activity Relationship | 3 | 2011 | 569 | 0.040 |
Why?
| | Nippostrongylus | 1 | 2021 | 5 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2004 | 439 | 0.040 |
Why?
| | Crystallization | 2 | 2012 | 138 | 0.040 |
Why?
| | Bacterial Load | 1 | 2020 | 67 | 0.040 |
Why?
| | Receptors, Interleukin | 2 | 2014 | 45 | 0.040 |
Why?
| | Histocompatibility Antigen H-2D | 1 | 1999 | 21 | 0.040 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2020 | 115 | 0.040 |
Why?
| | Male | 5 | 2025 | 72317 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2026 | 835 | 0.040 |
Why?
| | Cloning, Molecular | 2 | 2011 | 543 | 0.040 |
Why?
| | Spleen | 2 | 2000 | 518 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2024 | 743 | 0.040 |
Why?
| | Mice, Inbred Strains | 1 | 1999 | 399 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2019 | 124 | 0.040 |
Why?
| | Lysosomes | 1 | 2019 | 132 | 0.040 |
Why?
| | HLA-DQ Antigens | 1 | 2019 | 173 | 0.040 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 1 | 1998 | 16 | 0.040 |
Why?
| | Antigen-Antibody Reactions | 1 | 1998 | 50 | 0.030 |
Why?
| | CD3 Complex | 1 | 2018 | 112 | 0.030 |
Why?
| | DNA Repair | 1 | 2020 | 257 | 0.030 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 1998 | 37 | 0.030 |
Why?
| | Receptors, IgG | 1 | 1998 | 76 | 0.030 |
Why?
| | Ligands | 2 | 2010 | 674 | 0.030 |
Why?
| | Immunologic Techniques | 1 | 2017 | 39 | 0.030 |
Why?
| | Chickens | 1 | 1998 | 192 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 374 | 0.030 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2012 | 2600 | 0.030 |
Why?
| | Protein Domains | 1 | 2019 | 315 | 0.030 |
Why?
| | Cell Cycle | 1 | 2020 | 632 | 0.030 |
Why?
| | Mycobacterium phlei | 1 | 2016 | 1 | 0.030 |
Why?
| | Rhodococcus equi | 1 | 2016 | 1 | 0.030 |
Why?
| | Mice, Mutant Strains | 2 | 2007 | 306 | 0.030 |
Why?
| | Stem Cells | 1 | 2001 | 627 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2017 | 385 | 0.030 |
Why?
| | Pancreas | 1 | 2019 | 342 | 0.030 |
Why?
| | Mice, SCID | 2 | 2012 | 377 | 0.030 |
Why?
| | Bone Marrow Cells | 2 | 2010 | 322 | 0.030 |
Why?
| | Radiation Chimera | 1 | 2014 | 27 | 0.030 |
Why?
| | Smallpox Vaccine | 1 | 2014 | 24 | 0.030 |
Why?
| | Vaccinia | 1 | 2014 | 22 | 0.030 |
Why?
| | Receptors, Cytokine | 1 | 2014 | 36 | 0.030 |
Why?
| | Poly I-C | 1 | 2014 | 57 | 0.030 |
Why?
| | STAT Transcription Factors | 1 | 2014 | 24 | 0.030 |
Why?
| | Lectins, C-Type | 2 | 2007 | 63 | 0.030 |
Why?
| | Vaccines, Subunit | 1 | 2014 | 53 | 0.030 |
Why?
| | Base Sequence | 1 | 1998 | 2188 | 0.030 |
Why?
| | Listeriosis | 1 | 2014 | 65 | 0.030 |
Why?
| | Aging | 2 | 2002 | 1981 | 0.030 |
Why?
| | Transcriptome | 1 | 2020 | 1060 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2014 | 195 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 393 | 0.020 |
Why?
| | Alanine | 2 | 2008 | 169 | 0.020 |
Why?
| | Transplantation Chimera | 1 | 2013 | 57 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3635 | 0.020 |
Why?
| | Whole-Body Irradiation | 1 | 2013 | 78 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 1998 | 1056 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2012 | 119 | 0.020 |
Why?
| | Vaccines, Synthetic | 1 | 2012 | 140 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2012 | 59 | 0.020 |
Why?
| | Oligopeptides | 1 | 1993 | 268 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 2012 | 256 | 0.020 |
Why?
| | Transduction, Genetic | 1 | 2012 | 138 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 993 | 0.020 |
Why?
| | Molecular Mimicry | 1 | 2011 | 41 | 0.020 |
Why?
| | Carbohydrate Sequence | 1 | 2011 | 29 | 0.020 |
Why?
| | Tumor Burden | 1 | 2012 | 321 | 0.020 |
Why?
| | Germ-Line Mutation | 1 | 2012 | 174 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3634 | 0.020 |
Why?
| | Thermodynamics | 2 | 2008 | 424 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 423 | 0.020 |
Why?
| | Protein Engineering | 1 | 2011 | 124 | 0.020 |
Why?
| | Antigens, Tumor-Associated, Carbohydrate | 1 | 2009 | 8 | 0.020 |
Why?
| | Antigens, Neoplasm | 1 | 2012 | 330 | 0.020 |
Why?
| | Bronchial Hyperreactivity | 1 | 2010 | 102 | 0.020 |
Why?
| | Adaptation, Biological | 1 | 2009 | 54 | 0.020 |
Why?
| | Homeostasis | 2 | 2004 | 644 | 0.020 |
Why?
| | Chimera | 1 | 2009 | 61 | 0.020 |
Why?
| | Graft Rejection | 1 | 2012 | 538 | 0.020 |
Why?
| | Listeria monocytogenes | 1 | 2009 | 116 | 0.020 |
Why?
| | Precursor Cells, T-Lymphoid | 1 | 2008 | 1 | 0.020 |
Why?
| | Kinetics | 1 | 2011 | 1627 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1518 | 0.020 |
Why?
| | Lung | 1 | 2021 | 4192 | 0.020 |
Why?
| | Receptors, Interleukin-7 | 1 | 2007 | 28 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2008 | 362 | 0.020 |
Why?
| | Bone Marrow | 1 | 2009 | 305 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 2010 | 319 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2010 | 512 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2008 | 362 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2008 | 304 | 0.020 |
Why?
| | Species Specificity | 1 | 2008 | 576 | 0.020 |
Why?
| | Models, Biological | 1 | 1994 | 1838 | 0.020 |
Why?
| | Receptors, Immunologic | 1 | 2007 | 208 | 0.010 |
Why?
| | Receptors, Interleukin-2 | 1 | 2005 | 64 | 0.010 |
Why?
| | Amidohydrolases | 1 | 2004 | 32 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2004 | 95 | 0.010 |
Why?
| | GPI-Linked Proteins | 1 | 2004 | 83 | 0.010 |
Why?
| | Receptors, Interleukin-12 | 1 | 2003 | 6 | 0.010 |
Why?
| | CpG Islands | 1 | 2004 | 167 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2003 | 126 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 2004 | 178 | 0.010 |
Why?
| | Fluorescence | 1 | 2003 | 160 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 2003 | 154 | 0.010 |
Why?
| | Stromal Cells | 1 | 2003 | 129 | 0.010 |
Why?
| | Cloning, Organism | 1 | 2002 | 7 | 0.010 |
Why?
| | Freund's Adjuvant | 1 | 2002 | 18 | 0.010 |
Why?
| | Aluminum Hydroxide | 1 | 2002 | 13 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2004 | 766 | 0.010 |
Why?
| | Phosphoproteins | 1 | 2004 | 348 | 0.010 |
Why?
| | Liver | 1 | 2010 | 1856 | 0.010 |
Why?
| | Organ Specificity | 1 | 2001 | 315 | 0.010 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily B | 1 | 2000 | 9 | 0.010 |
Why?
| | Cell Division | 1 | 2002 | 780 | 0.010 |
Why?
| | Antigens, Ly | 1 | 2000 | 41 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 2004 | 422 | 0.010 |
Why?
| | Aged | 1 | 2020 | 25862 | 0.010 |
Why?
| | Intestine, Large | 1 | 2000 | 14 | 0.010 |
Why?
| | Antigens, Surface | 1 | 2000 | 157 | 0.010 |
Why?
| | Dimerization | 1 | 2000 | 194 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2004 | 750 | 0.010 |
Why?
| | Leukocyte Common Antigens | 1 | 2000 | 88 | 0.010 |
Why?
| | Clonal Anergy | 1 | 2000 | 55 | 0.010 |
Why?
| | Lymphocyte Depletion | 1 | 2000 | 135 | 0.010 |
Why?
| | CD4 Antigens | 1 | 2000 | 144 | 0.010 |
Why?
| | Chromatin | 1 | 2003 | 557 | 0.010 |
Why?
| | Animals, Newborn | 1 | 2002 | 904 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 36003 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2004 | 1184 | 0.010 |
Why?
| | Leucine | 1 | 1998 | 116 | 0.010 |
Why?
| | Adult | 1 | 2020 | 40538 | 0.010 |
Why?
| | Point Mutation | 1 | 1998 | 245 | 0.010 |
Why?
| | Vaccines | 1 | 2002 | 389 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2003 | 1134 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1998 | 944 | 0.010 |
Why?
| | Antigens, CD | 1 | 1998 | 564 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1994 | 192 | 0.010 |
Why?
| | Endopeptidases | 1 | 1994 | 80 | 0.010 |
Why?
| | Proteins | 1 | 2000 | 1029 | 0.010 |
Why?
| | Dansyl Compounds | 1 | 1993 | 4 | 0.010 |
Why?
| | Plasmodium berghei | 1 | 1993 | 7 | 0.010 |
Why?
| | Organelles | 1 | 1994 | 59 | 0.010 |
Why?
| | Endocytosis | 1 | 1994 | 171 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 1993 | 224 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1993 | 564 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1993 | 1358 | 0.010 |
Why?
|
|
Gapin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|